XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.2
FAIR VALUE (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of fair values of financial assets and liabilities
As of June 30, 2024, the fair values of our financial assets and liabilities were categorized as follows:
TotalLevel 1Level 2Level 3
Assets
Investment in equity securities (1)
$1,725 $1,725 $— $— 
Foreign exchange contracts (2)
949 — 949 — 
Convertible notes (3)
5,650 — — 5,650 
Total assets at fair value$8,324 $1,725 $949 $5,650 
Liabilities
Foreign exchange contracts (2)
$646 $— $646 $— 
Cross currency swap contract (2)
14,901 — 14,901 — 
Total liabilities at fair value$15,547 $— $15,547 $— 
As of December 31, 2023, the fair values of our financial assets and liabilities were categorized as follows:
TotalLevel 1Level 2Level 3
Assets
Investment in equity securities (1)
$1,106 $1,106 $— $— 
Foreign exchange contracts (2)
386 — 386 — 
Convertible note  (3)
5,650 — — 5,650 
Total assets at fair value$7,142 $1,106 $386 $5,650 
Liabilities
Foreign exchange contracts (2)
$221 $— $221 $— 
Cross currency swap contract (2)
22,199 — 22,199 — 
Total liabilities at fair value$22,420 $— $22,420 $— 
________________________________________________
(1)Investment in PureCycle Technologies (“PCT” or “PureCycle”). See Note 18 – Investment in Equity Securities for discussion of this investment.
(2)Market approach valuation technique based on observable market transactions of spot and forward rates.
(3)Investment in convertible notes in Enable Injections, Inc. and Siklus Refill Pte, Ltd. The investments are included within Miscellaneous assets in our Condensed Consolidated Balance Sheets.